1 year return (CAGR)
8.15%
ACADIA Pharmaceuticals Inc Exchange (NASDAQ, USD)
ACAD
20.68
+0.01 (+0.04%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
2.23%
5 year return (CAGR)
10.85%
10 year return (CAGR)
-2.04%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
4.55B
Price/Sales
4.00
Ent value
4.60B
Price/Book
3.48
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
11.96
PEG
-
Forward P/E
29.67
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 26.65 |
| Daily high | 26.86 |
| Daily low | 26.32 |
| Daily Volume | 1.44M |
| All-time high | 57.00 |
| 1y analyst estimate | 34.00 |
| Beta | 0.84 |
| EPS (TTM) | 2.20 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 2 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ACAD | S&P500 | |
| Current price drop from All-time high | -63.72% | -0.84% |
| Highest price drop | -96.29% | -56.47% |
| Date of highest drop | 12 Nov 2010 | 9 Mar 2009 |
| Avg drop from high | -50.21% | -10.68% |
| Avg time to new high | 60 days | 12 days |
| Max time to new high | 1820 days | 1805 days |
News
